BPC-157 (5 mg) 98 € + Shipping ^Sale

BPC-157 (Body Protection Compound-157) is a stable 15-amino-acid pentadecapeptide derived from a partial sequence of a human gastric-juice protein. It is studied as a cytoprotective and pro-angiogenic regulator acting through VEGFR2 and FAK–paxillin signaling. This product is supplied as a lyophilized research-grade peptide for in vitro and preclinical laboratory investigation only.

Investigational directions enabled by the published mechanism — not therapeutic claims.

• ◆Tissue repair & regeneration: fibroblast activity and collagen production in tendon, muscle and ligament models
• ◆Angiogenesis: new blood-vessel formation via VEGFR2 signaling
• ◆Neurological research: nerve regeneration and functional recovery in injury models
• ◆Gastrointestinal cytoprotection: gastric-ulcer and inflammatory-bowel-type experimental models

In published models, BPC-157 drives angiogenesis and endothelial repair through the VEGFR2–PI3K–Akt–eNOS axis, while FAK–paxillin activation supports cell migration and tendon/ligament outgrowth. It upregulates the growth-hormone receptor on tendon fibroblasts and modulates the NO system (eNOS↑ / iNOS↓) toward cytoprotection and radical scavenging.

Key literature: Chang et al., 2011, J Appl Physiol · Staresinic et al., 2003 · Seiwerth et al., 2021 · Perovic et al., 2019.

Evidence note: approximately 80% of the BPC-157 literature originates from a single research group (Sikiric, Zagreb); independent replication remains limited.